The National Institute on Health Abuse suggests that polymorphisms of catechol-O-methyltransferase (COMT) and alpha serine/threonine-protein kinase (AKT1) genes may affect the response to cannabis and predict the possible risk of psychosis and cognitive impairment [391,392]. The gene discussed is AKT1; the disease is psychotic disorder.